IBDEI0F1 ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20189,1,3,0)
 ;;=3^599.70
 ;;^UTILITY(U,$J,358.3,20189,1,4,0)
 ;;=4^HEMATURIA,UNSPEC
 ;;^UTILITY(U,$J,358.3,20189,2)
 ;;=^336751
 ;;^UTILITY(U,$J,358.3,20190,0)
 ;;=599.71^^104^1163^11
 ;;^UTILITY(U,$J,358.3,20190,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20190,1,3,0)
 ;;=3^599.71
 ;;^UTILITY(U,$J,358.3,20190,1,4,0)
 ;;=4^HEMATURIA,GROSS
 ;;^UTILITY(U,$J,358.3,20190,2)
 ;;=^336611
 ;;^UTILITY(U,$J,358.3,20191,0)
 ;;=599.72^^104^1163^12
 ;;^UTILITY(U,$J,358.3,20191,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20191,1,3,0)
 ;;=3^599.72
 ;;^UTILITY(U,$J,358.3,20191,1,4,0)
 ;;=4^HEMATURIA,MICROSCOPIC
 ;;^UTILITY(U,$J,358.3,20191,2)
 ;;=^336612
 ;;^UTILITY(U,$J,358.3,20192,0)
 ;;=607.84^^104^1163^14
 ;;^UTILITY(U,$J,358.3,20192,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20192,1,3,0)
 ;;=3^607.84
 ;;^UTILITY(U,$J,358.3,20192,1,4,0)
 ;;=4^IMPOTENCE, ORGANIC ORIGN
 ;;^UTILITY(U,$J,358.3,20192,2)
 ;;=^270441
 ;;^UTILITY(U,$J,358.3,20193,0)
 ;;=604.99^^104^1163^15
 ;;^UTILITY(U,$J,358.3,20193,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20193,1,3,0)
 ;;=3^604.99
 ;;^UTILITY(U,$J,358.3,20193,1,4,0)
 ;;=4^ORCHITIS/EPIDIDYMITIS NEC
 ;;^UTILITY(U,$J,358.3,20193,2)
 ;;=^270432
 ;;^UTILITY(U,$J,358.3,20194,0)
 ;;=605.^^104^1163^16
 ;;^UTILITY(U,$J,358.3,20194,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20194,1,3,0)
 ;;=3^605.
 ;;^UTILITY(U,$J,358.3,20194,1,4,0)
 ;;=4^PHIMOSIS
 ;;^UTILITY(U,$J,358.3,20194,2)
 ;;=^104159
 ;;^UTILITY(U,$J,358.3,20195,0)
 ;;=185.^^104^1163^17
 ;;^UTILITY(U,$J,358.3,20195,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20195,1,3,0)
 ;;=3^185.
 ;;^UTILITY(U,$J,358.3,20195,1,4,0)
 ;;=4^PROSTATE CANCER
 ;;^UTILITY(U,$J,358.3,20195,2)
 ;;=^99481
 ;;^UTILITY(U,$J,358.3,20196,0)
 ;;=600.10^^104^1163^18
 ;;^UTILITY(U,$J,358.3,20196,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20196,1,3,0)
 ;;=3^600.10
 ;;^UTILITY(U,$J,358.3,20196,1,4,0)
 ;;=4^PROSTATE NODULE
 ;;^UTILITY(U,$J,358.3,20196,2)
 ;;=^329934
 ;;^UTILITY(U,$J,358.3,20197,0)
 ;;=601.8^^104^1163^19
 ;;^UTILITY(U,$J,358.3,20197,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20197,1,3,0)
 ;;=3^601.8
 ;;^UTILITY(U,$J,358.3,20197,1,4,0)
 ;;=4^PROSTATIS
 ;;^UTILITY(U,$J,358.3,20197,2)
 ;;=^270420
 ;;^UTILITY(U,$J,358.3,20198,0)
 ;;=791.0^^104^1163^20
 ;;^UTILITY(U,$J,358.3,20198,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20198,1,3,0)
 ;;=3^791.0
 ;;^UTILITY(U,$J,358.3,20198,1,4,0)
 ;;=4^PROTEINURIA
 ;;^UTILITY(U,$J,358.3,20198,2)
 ;;=^99873
 ;;^UTILITY(U,$J,358.3,20199,0)
 ;;=590.80^^104^1163^21
 ;;^UTILITY(U,$J,358.3,20199,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20199,1,3,0)
 ;;=3^590.80
 ;;^UTILITY(U,$J,358.3,20199,1,4,0)
 ;;=4^PYELONEPHRITIS NOS
 ;;^UTILITY(U,$J,358.3,20199,2)
 ;;=^101463
 ;;^UTILITY(U,$J,358.3,20200,0)
 ;;=592.0^^104^1163^22
 ;;^UTILITY(U,$J,358.3,20200,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20200,1,3,0)
 ;;=3^592.0
 ;;^UTILITY(U,$J,358.3,20200,1,4,0)
 ;;=4^RENAL CALCULI
 ;;^UTILITY(U,$J,358.3,20200,2)
 ;;=^67056
 ;;^UTILITY(U,$J,358.3,20201,0)
 ;;=597.80^^104^1163^23
 ;;^UTILITY(U,$J,358.3,20201,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20201,1,3,0)
 ;;=3^597.80
 ;;^UTILITY(U,$J,358.3,20201,1,4,0)
 ;;=4^URETHRITIS NOS
 ;;^UTILITY(U,$J,358.3,20201,2)
 ;;=^124214
 ;;^UTILITY(U,$J,358.3,20202,0)
 ;;=788.30^^104^1163^25
 ;;^UTILITY(U,$J,358.3,20202,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20202,1,3,0)
 ;;=3^788.30
 ;;^UTILITY(U,$J,358.3,20202,1,4,0)
 ;;=4^URINARY INCONTINENCE
 ;;^UTILITY(U,$J,358.3,20202,2)
 ;;=^124400
 ;;^UTILITY(U,$J,358.3,20203,0)
 ;;=599.0^^104^1163^24
 ;;^UTILITY(U,$J,358.3,20203,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20203,1,3,0)
 ;;=3^599.0
 ;;^UTILITY(U,$J,358.3,20203,1,4,0)
 ;;=4^URIN TRACT INFECTION NOS
 ;;^UTILITY(U,$J,358.3,20203,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,20204,0)
 ;;=585.1^^104^1163^2
 ;;^UTILITY(U,$J,358.3,20204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20204,1,3,0)
 ;;=3^585.1
 ;;^UTILITY(U,$J,358.3,20204,1,4,0)
 ;;=4^CHR KIDNEY DIS STAGE I
 ;;^UTILITY(U,$J,358.3,20204,2)
 ;;=^332807
 ;;^UTILITY(U,$J,358.3,20205,0)
 ;;=585.2^^104^1163^3
 ;;^UTILITY(U,$J,358.3,20205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20205,1,3,0)
 ;;=3^585.2
 ;;^UTILITY(U,$J,358.3,20205,1,4,0)
 ;;=4^CHR KIDNEY DIS STAGE II
 ;;^UTILITY(U,$J,358.3,20205,2)
 ;;=^332808
 ;;^UTILITY(U,$J,358.3,20206,0)
 ;;=585.3^^104^1163^4
 ;;^UTILITY(U,$J,358.3,20206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20206,1,3,0)
 ;;=3^585.3
 ;;^UTILITY(U,$J,358.3,20206,1,4,0)
 ;;=4^CHR KIDNEY DIS STAGE III
 ;;^UTILITY(U,$J,358.3,20206,2)
 ;;=^332809
 ;;^UTILITY(U,$J,358.3,20207,0)
 ;;=585.4^^104^1163^5
 ;;^UTILITY(U,$J,358.3,20207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20207,1,3,0)
 ;;=3^585.4
 ;;^UTILITY(U,$J,358.3,20207,1,4,0)
 ;;=4^CHR KIDNEY DIS STAGE IV
 ;;^UTILITY(U,$J,358.3,20207,2)
 ;;=^332810
 ;;^UTILITY(U,$J,358.3,20208,0)
 ;;=585.5^^104^1163^6
 ;;^UTILITY(U,$J,358.3,20208,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20208,1,3,0)
 ;;=3^585.5
 ;;^UTILITY(U,$J,358.3,20208,1,4,0)
 ;;=4^CHR KIDNEY DIS STAGE V
 ;;^UTILITY(U,$J,358.3,20208,2)
 ;;=^332811
 ;;^UTILITY(U,$J,358.3,20209,0)
 ;;=585.6^^104^1163^10
 ;;^UTILITY(U,$J,358.3,20209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20209,1,3,0)
 ;;=3^585.6
 ;;^UTILITY(U,$J,358.3,20209,1,4,0)
 ;;=4^ESRD
 ;;^UTILITY(U,$J,358.3,20209,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,20210,0)
 ;;=281.1^^104^1164^2
 ;;^UTILITY(U,$J,358.3,20210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20210,1,3,0)
 ;;=3^281.1
 ;;^UTILITY(U,$J,358.3,20210,1,4,0)
 ;;=4^ANEMIA,B12 DEF
 ;;^UTILITY(U,$J,358.3,20210,2)
 ;;=^267974
 ;;^UTILITY(U,$J,358.3,20211,0)
 ;;=281.2^^104^1164^3
 ;;^UTILITY(U,$J,358.3,20211,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20211,1,3,0)
 ;;=3^281.2
 ;;^UTILITY(U,$J,358.3,20211,1,4,0)
 ;;=4^ANEMIA,FOLATE DEF
 ;;^UTILITY(U,$J,358.3,20211,2)
 ;;=^259686
 ;;^UTILITY(U,$J,358.3,20212,0)
 ;;=280.9^^104^1164^4
 ;;^UTILITY(U,$J,358.3,20212,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20212,1,3,0)
 ;;=3^280.9
 ;;^UTILITY(U,$J,358.3,20212,1,4,0)
 ;;=4^ANEMIA,IRON DEF
 ;;^UTILITY(U,$J,358.3,20212,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,20213,0)
 ;;=285.8^^104^1164^1
 ;;^UTILITY(U,$J,358.3,20213,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20213,1,3,0)
 ;;=3^285.8
 ;;^UTILITY(U,$J,358.3,20213,1,4,0)
 ;;=4^ANEMIA NEC
 ;;^UTILITY(U,$J,358.3,20213,2)
 ;;=^87876
 ;;^UTILITY(U,$J,358.3,20214,0)
 ;;=282.2^^104^1164^5
 ;;^UTILITY(U,$J,358.3,20214,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20214,1,3,0)
 ;;=3^282.2
 ;;^UTILITY(U,$J,358.3,20214,1,4,0)
 ;;=4^G6PD DEFICIENCY
 ;;^UTILITY(U,$J,358.3,20214,2)
 ;;=^7225
 ;;^UTILITY(U,$J,358.3,20215,0)
 ;;=V08.^^104^1164^6
 ;;^UTILITY(U,$J,358.3,20215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20215,1,3,0)
 ;;=3^V08.
 ;;^UTILITY(U,$J,358.3,20215,1,4,0)
 ;;=4^HIV+ (ASYMPTOMATIC)
 ;;^UTILITY(U,$J,358.3,20215,2)
 ;;=^303392
 ;;^UTILITY(U,$J,358.3,20216,0)
 ;;=279.3^^104^1164^7
 ;;^UTILITY(U,$J,358.3,20216,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20216,1,3,0)
 ;;=3^279.3
 ;;^UTILITY(U,$J,358.3,20216,1,4,0)
 ;;=4^IMMUNITY DEFICIENCY NOS
 ;;^UTILITY(U,$J,358.3,20216,2)
 ;;=^267969
 ;;^UTILITY(U,$J,358.3,20217,0)
 ;;=785.6^^104^1164^8
 ;;^UTILITY(U,$J,358.3,20217,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20217,1,3,0)
 ;;=3^785.6
 ;;^UTILITY(U,$J,358.3,20217,1,4,0)
 ;;=4^LYMPHADENOPATHY
 ;;^UTILITY(U,$J,358.3,20217,2)
 ;;=^72368
 ;;^UTILITY(U,$J,358.3,20218,0)
 ;;=075.^^104^1164^9
 ;;^UTILITY(U,$J,358.3,20218,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20218,1,3,0)
 ;;=3^075.
 ;;^UTILITY(U,$J,358.3,20218,1,4,0)
 ;;=4^MONONUCLEOSIS
 ;;^UTILITY(U,$J,358.3,20218,2)
 ;;=^62797
 ;;^UTILITY(U,$J,358.3,20219,0)
 ;;=238.4^^104^1164^10
 ;;^UTILITY(U,$J,358.3,20219,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20219,1,3,0)
 ;;=3^238.4
 ;;^UTILITY(U,$J,358.3,20219,1,4,0)
 ;;=4^POLYCYTHEMIA VERA
 ;;^UTILITY(U,$J,358.3,20219,2)
 ;;=^304816
 ;;^UTILITY(U,$J,358.3,20220,0)
 ;;=282.49^^104^1164^11
 ;;^UTILITY(U,$J,358.3,20220,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20220,1,3,0)
 ;;=3^282.49
 ;;^UTILITY(U,$J,358.3,20220,1,4,0)
 ;;=4^THALASSEMIA NEC
 ;;^UTILITY(U,$J,358.3,20220,2)
 ;;=^329910
 ;;^UTILITY(U,$J,358.3,20221,0)
 ;;=287.5^^104^1164^12
 ;;^UTILITY(U,$J,358.3,20221,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20221,1,3,0)
 ;;=3^287.5
 ;;^UTILITY(U,$J,358.3,20221,1,4,0)
 ;;=4^THROMBOCYTOPENIA NOS
 ;;^UTILITY(U,$J,358.3,20221,2)
 ;;=^118988
 ;;^UTILITY(U,$J,358.3,20222,0)
 ;;=289.9^^104^1164^13
 ;;^UTILITY(U,$J,358.3,20222,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20222,1,3,0)
 ;;=3^289.9
 ;;^UTILITY(U,$J,358.3,20222,1,4,0)
 ;;=4^THROMBOCYTOSIS
 ;;^UTILITY(U,$J,358.3,20222,2)
 ;;=^55344
 ;;^UTILITY(U,$J,358.3,20223,0)
 ;;=401.9^^104^1165^1
 ;;^UTILITY(U,$J,358.3,20223,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20223,1,3,0)
 ;;=3^401.9
 ;;^UTILITY(U,$J,358.3,20223,1,4,0)
 ;;=4^HYPERTENSION NOS
 ;;^UTILITY(U,$J,358.3,20223,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,20224,0)
 ;;=401.1^^104^1165^3
 ;;^UTILITY(U,$J,358.3,20224,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20224,1,3,0)
 ;;=3^401.1
 ;;^UTILITY(U,$J,358.3,20224,1,4,0)
 ;;=4^HYPERTENSION,BENIGN
 ;;^UTILITY(U,$J,358.3,20224,2)
 ;;=^269591
 ;;^UTILITY(U,$J,358.3,20225,0)
 ;;=401.0^^104^1165^2
 ;;^UTILITY(U,$J,358.3,20225,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20225,1,3,0)
 ;;=3^401.0
 ;;^UTILITY(U,$J,358.3,20225,1,4,0)
 ;;=4^HYPERTENSION,ACCELERATED
 ;;^UTILITY(U,$J,358.3,20225,2)
 ;;=^73505
 ;;^UTILITY(U,$J,358.3,20226,0)
 ;;=227.0^^104^1166^1
 ;;^UTILITY(U,$J,358.3,20226,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20226,1,3,0)
 ;;=3^227.0
 ;;^UTILITY(U,$J,358.3,20226,1,4,0)
 ;;=4^ADRENAL NEOPLASM,BENIGN
 ;;^UTILITY(U,$J,358.3,20226,2)
 ;;=^267688
 ;;^UTILITY(U,$J,358.3,20227,0)
 ;;=194.0^^104^1166^2
 ;;^UTILITY(U,$J,358.3,20227,1,0)
 ;;=^358.31IA^4^2
